---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-314728"
form_type: "8-K"
ticker: "FULC"
cik: "0001680581"
company_name: "Fulcrum Therapeutics, Inc."
filed_at: "2025-12-11T23:59:59+00:00"
generated_at: "2026-05-16T13:31:08.256048+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Fulcrum Therapeutics prices $175M upsized public offering of common stock and pre-funded warrants

## Summary
- Priced underwritten offering of 11,851,853 shares at $13.50/share and pre-funded warrants for 1,111,193 shares at $13.499 each.
- Gross proceeds of $175M; net proceeds estimated at $164.1M (or $188.1M if underwriter option exercised).
- Offering upsized; underwriters granted 30-day option to purchase up to 1,944,456 additional shares.
- Net proceeds to fund general corporate purposes, including R&D, clinical trials, and potential acquisitions.
- Closing expected on or about December 11, 2025, subject to customary conditions.

## SEC filing metadata
- accession: 0001193125-25-314728
- form_type: 8-K
- ticker: FULC
- cik: 0001680581
- company_name: Fulcrum Therapeutics, Inc.
- filed_at: 2025-12-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1680581/000119312525314728/0001193125-25-314728-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1680581/000119312525314728/fulc-20251210.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-314728
- JSON: https://secwatch.observer/filing/0001193125-25-314728.json
- Plain text: https://secwatch.observer/filing/0001193125-25-314728.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.